This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ensemble Therapeutics Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Cheri Snedeker: Innovator in Macrocyclic Compounds
Introduction
Cheri Snedeker is a notable inventor based in Nashua, NH, who has made significant contributions to the field of medicinal chemistry. She is recognized for her innovative work in developing macrocyclic compounds that have therapeutic applications.
Latest Patents
Cheri holds a patent for "Macrocyclic compounds for modulating IL-17." This invention focuses on macrocyclic compounds that modulate the activity of IL-17, which is crucial in the treatment of various inflammatory diseases and IL-17-associated disorders. The patent highlights the potential of these compounds in addressing significant medical conditions.
Career Highlights
Cheri is currently associated with Ensemble Therapeutics Corporation, where she continues to advance her research and development efforts. Her work has positioned her as a key player in the field of therapeutic innovations.
Collaborations
Cheri has collaborated with notable colleagues, including Michael Taylor and Nicholas K Terrett, contributing to a dynamic research environment that fosters innovation.
Conclusion
Cheri Snedeker's contributions to the field of macrocyclic compounds exemplify her dedication to advancing medical science. Her innovative work continues to pave the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile